This stance is further supported by Havelund et al. [49], who found that HIF-1α (and GLUT-1) was not associated with a difference in tumour response post nCRT when assessed using the Mandard Tumour Regression Grading System (TRG). This evidence concerns the gene HIF1A and neoplasm.